Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 29Unknown 8Recruiting 8Withdrawn 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Endocrine 1Breast 1

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Papillary Thyroid Microcarcinoma 1Breast Neoplasms 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 116Bevacizumab 102Capecitabine 100Oxaliplatin 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 85pembrolizumab 77Specimen Handling 77toripalimab 70Magnetic Resonance Spectroscopy 63Injections 63Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 51fludarabine 47Standard of Care 45Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43venetoclax 42Leucovorin 42lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Decision Support Techniques × Clear all
NCT07497256 2026-04-30

BCT Aid

Xiamen University

Phase NA Not yet recruiting
160 enrolled
Breast

Breast Neoplasms

NCT07536412 2026-04-17

Decision Aid Efficacy in Low Risk Thyroid Cancer

University of Maryland, Baltimore

Phase NA Not yet recruiting
34 enrolled
EndocrineHead & Neck

Papillary Thyroid Microcarcinoma, Thyroid Cancer, Papillary, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡